Horizon 2020 recent events

The Northern Ireland Contact Point network recently held a number of workshops on the upcoming work programs of Horizon 2020. These included: Biotechnology and Engineering work program launch. This event on the Focused on the Engineering and ICT calls in the Biotechnology and nanotechnology areas. Attendees received information about the programs and details of specific […]

View Post

The importance of the NICP Network

Professor Neil Hewitt of Ulster University explains the need for energy storage in Northern Ireland and the importance of the role of the NICP network in supporting successful applications to the fund. http://www.energyireland.ie/the-need-for-energy-storage-in-northern-ireland/

View Post

Cyber Security Brokerage Event in Brussels

DETI in conjunction with the ERRIN network hosted a Cyber Security brokerage event in the offices of the Northern Ireland Assembly in Brussels on the 30th September. Over 60 cyber security experts from across Europe heard up to date information on the upcoming Cyber Security calls in Horizon 2020. Case studies showcasing cyber security successes in H2020 […]

View Post

Northern Ireland SME secures €1.2Million from Horizon 2020

MOF Technologies, a Northern Ireland SME has secured funding of €1.2Million from Horizon 2020. The company has collaborated with industry giants such as IBM and General Motors in securing the funding for clean tech gas storage systems. This fantastic success story highlights the expertise in the local Northern Ireland SME community and how local companies can […]

View Post

Northern Ireland Secures €15.5 million in Horizon 2020 grant funding

            Between  1 January 2014  – 30 June  2015 Northern Irish Researchers  in  academia, the private , public sectors  have successfully secured €15.5 million  in Horizon 2020 grant funding. This competitively won funding was secured with the help and assistance of the Northern Ireland Contact Point Network (NICP). The Northern Ireland […]

View Post

Queen’s University Wins €23.3m from the Innovative Medicines Initiative (IMI) programme to develop new antibiotic treatments for cystic fibrosis and bronchiectasis

  Researchers at Queen’s are leading a €50 million, Europe-wide, project to develop new drug treatments that could improve the lives of patients with cystic fibrosis and bronchiectasis. The iABC (inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis) consortium, which is made up of world-leading lung specialists from across Europe, will develop new ‘inhaled antibiotics’ to […]

View Post